10-K Filing

Company

Cellectar Biosciences, Inc.

Filed

April 14, 2011

Period of Report

December 31, 2010

Accession Number

0001144204-11-022037

A 10-K is a company's comprehensive annual report, required by the SEC. It includes audited financial statements, a description of the business, risk factors, and management's discussion of results. Learn more about 10-K filings →